Milestone Pharmaceuticals Faces FDA Regulatory Risks, Stock Target Suggests High Upside Milestone Pharmaceuticals (MIST) is navigating potential operational delays stemming from regulatory scrutiny, according to a recent disclosure. The company …
Tag: